Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Johnson and Johnson | 930 |
| 2 | Pfizer Inc | 900 |
| 3 | Takeda Pharmaceutical Co Ltd | 653 |
| 4 | Novo Nordisk Fonden | 615 |
| 5 | C.H. Boehringer Sohn AG and Co KG | 414 |
| 6 | University of California | 354 |
| 7 | Roche Holding AG | 341 |
| 8 | BioNTech SE | 327 |
| 9 | Ferring Holding SA | 310 |
| 10 | Bayer AG | 278 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 27,341 |
| 2 | A61P | Therapeutic activity (drug indications) | 22,091 |
| 3 | C07K | Peptides | 9,627 |
| 4 | C12N | Microorganisms, enzymes | 7,139 |
| 5 | C07D | Heterocyclic compounds | 5,898 |
| 6 | G01N | Investigating / analysing materials | 4,556 |
| 7 | A61M | Devices for introducing media into the body | 3,858 |
| 8 | Y02A | Climate change adaptation | 2,888 |
| 9 | C07C | Acyclic and carbocyclic compounds | 2,236 |
| 10 | A61B | 1,839 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Tocolytic oxytocin receptor antagonists | 1995 | Merck and Co Inc | 134 |
| Closed-loop system for infusing oxytocin | 1996 | 131 | |
| Tocolytic oxytocin receptor antagonists | 1998 | Merck and Co Inc | 112 |
| 1,6 - SUBSTITUTED (3R,6R) -3- (2,3-DIHYDRO-1H-INDEN-2-YL)-2,5-PIPERAZINEDIONE DERIVATIVES AS OXYTOCIN RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PRE-TERM LABOUR, DYSMENORRHEA AND ENDOMETRIOSIS | 2006 | GSK PLC | 81 |
| Carbostyril oxytocin receptor antagonists | 1994 | Merck and Co Inc | 79 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 463 |
| 2017 | 574 |
| 2018 | 502 |
| 2019 | 476 |
| 2020 | 492 |
| 2021 | 554 |
| 2022 | 495 |
| 2023 | 445 |
| 2024 | 416 |
| 2025 | 201 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Gareth Leng | University of Edinburgh | 100 |
| 2 | Inga D. Neumann | University of Regensburg | 91 |
| 3 | Keith M. Kendrick | University of Electronic Science and Technology of China | 70 |
| 4 | Larry J. Young | Emory University | 70 |
| 5 | Kerstin Uvnäs‐Moberg | Karolinska Institutet | 68 |
| 6 | Vincent du Vigneaud | Cornell University | 59 |
| 7 | Yoichi Ueta | University of Occupational and Environmental Health Japan | 52 |
| 8 | Janet A. Amico | University of Pittsburgh | 49 |
| 9 | Roderich Walter | City University of New York | 49 |
| 10 | Anna‐Riitta Fuchs | Cornell University | 46 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Oxytocin increases trust in humans | 2005 | 3693 | Attachment and Relationship Dynamics |
| The Oxytocin Receptor System: Structure, Function, and Regulation | 2001 | 3093 | Hypothalamic control of reproductive hormones |
| Rapid analysis of amino acids using pre-column derivatization | 1984 | 2522 | Analytical Chemistry and Chromatography |
| Mechanisms of action of transmitters and other substances on smooth muscle. | 1979 | 2194 | Pharmacological Effects of Natural Compounds |
| Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress | 2003 | 2098 | Child and Adolescent Psychosocial and Emotional Development |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of oxytocin?
Which organizations hold the most patents related to oxytocin?
What are the most-cited landmark papers on oxytocin in the knowledge base?
Who are the most prolific researchers publishing on oxytocin?
What are the primary patent classification areas for oxytocin-related inventions?